The Aptima SARS-CoV-2 Assay is an in vitro diagnostic test that detects SARS-CoV-2 RNA from nasopharyngeal (NP) or nasal swab samples obtained from people exhibiting signs and symptoms of a ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Hologic's Aptima SARS-CoV-2 assay ... RNA from nasopharyngeal (NP) or nasal swab samples collected from individuals ...
The Aptima SARS-CoV-2 Assay is an in vitro diagnostic test that detects SARS-CoV-2 RNA from nasopharyngeal (NP) or nasal swab samples obtained from people exhibiting signs and symptoms of a ...
The following is a summary of “Diagnostic-avoiding Chlamydia trachomatis variants detected in cervical and endometrial ...
Orlando, March 13, 2025 (GLOBE NEWSWIRE) -- Aptima Inc., a leader in optimizing human performance through innovative technologies, announced today a contract award sponsored by the Naval Air ...
Orlando, March 13, 2025 (GLOBE NEWSWIRE) -- Aptima Inc., a leader in optimizing human performance through innovative technologies, announced today a contract award sponsored by the Naval Air Warfare ...
MASTER' blends VR with neurophysiology to provide pilots more realistic, immersive, and engaging SD training to ensure readiness Orlando, March 13, 2025 (GLOBE NEWSWIRE) -- Aptima Inc., a leader in ...
Urine specimens, self-collected vaginal, rectal or pharyngeal swabs and tampon specimens can all be used for chlamydia testing with NAATs. However, where sampling methods have not been approved by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback